Analystreport

Nabriva Therapeutics plc (NASDAQ: NBRV) had its price target lowered by analysts at Northland Securities from $9.00 to $6.00. They now have an "outperform" rating o

Nabriva Therapeutics plc - Ordinary Shares  (NBRV) 
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.nabriva.com/investor-relations